Reduced maternal corticosteroid‐binding globulin and cortisol levels in pre‐eclampsia and gamete recipient pregnancies

Objective  To measure and contrast maternal cortisol and corticosteroid‐binding globulin (CBG) levels in pregnancies with normal outcomes, pre‐eclampsia, intrauterine growth restriction (IUGR) and in gamete recipients.

[1]  C. Osmond,et al.  Thinness at birth and insulin resistance in adult life , 1994, Diabetologia.

[2]  A. Chicz–DeMet,et al.  Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH): Priming the placental clock , 2006, Peptides.

[3]  M. J. Chapman,et al.  Septic shock and sepsis: a comparison of total and free plasma cortisol levels. , 2006, The Journal of clinical endocrinology and metabolism.

[4]  N. Sagawa,et al.  [Intrauterine growth retardation]. , 1993, Ryoikibetsu shokogun shirizu.

[5]  B. V. Van Voorhis.  Outcomes from assisted reproductive technology. , 2006, Obstetrics and gynecology.

[6]  L. Nieman,et al.  The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. , 2005, Endocrine reviews.

[7]  D. Torpy,et al.  Pregnancy-associated corticosteroid-binding globulin: high resolution separation of glycan isoforms. , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[8]  Mark G. Lewis,et al.  An enzyme-linked immunosorbent assay for corticosteroid-binding globulin using monoclonal and polyclonal antibodies: decline in CBG following synthetic ACTH. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[9]  G. Pals,et al.  Searching for preeclampsia genes: the current position. , 2002, European journal of obstetrics, gynecology, and reproductive biology.

[10]  N. Page.  The endocrinology of pre‐eclampsia , 2002, Clinical endocrinology.

[11]  P. McKeigue,et al.  Skeletal muscle glucocorticoid receptor density and insulin resistance. , 2002, JAMA.

[12]  C. Byrne,et al.  Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. , 2002, Diabetes.

[13]  G. Dekker,et al.  Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia , 2002, The Lancet.

[14]  M. Varner,et al.  Paternal and maternal components of the predisposition to preeclampsia. , 2001, The New England journal of medicine.

[15]  F. Ferré,et al.  Corticosteroid-Binding Globulin Status at the Fetomaternal Interface During Human Term Pregnancy1 , 2001, Biology of reproduction.

[16]  G. Dekker,et al.  Primary, secondary, and tertiary prevention of pre-eclampsia , 2001, The Lancet.

[17]  Jean-Marie Moutquin,et al.  The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.

[18]  J. Moutquin,et al.  The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). , 2001 .

[19]  J. Seckl,et al.  Glucocorticoids, 11β-hydroxysteroid dehydrogenase, and fetal programming , 2000 .

[20]  J. Gardosi,et al.  Customized fetal weight limits for antenatal detection of fetal growth restriction , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[21]  R. Azziz,et al.  Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. , 2000, The Journal of clinical endocrinology and metabolism.

[22]  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. , 2000, American journal of obstetrics and gynecology.

[23]  M. Faas,et al.  Etiology and pathogenesis of preeclampsia: current concepts. , 1999, American journal of obstetrics and gynecology.

[24]  J. Whitworth,et al.  CORTISOL AND HYPERTENSION , 1998, Clinical and experimental pharmacology & physiology. Supplement.

[25]  R. T. Lie,et al.  Fetal and maternal contributions to risk of pre-eclampsia: population based study , 1998, BMJ.

[26]  M. Divon,et al.  Etiologies of fetal growth restriction. , 1997, Clinical obstetrics and gynecology.

[27]  C. Stournaras,et al.  Endometrial Corticotropin‐Releasing Hormone , 1997 .

[28]  D J Barker,et al.  Fetal origins of coronary heart disease , 1995, BMJ.

[29]  C. Damsky,et al.  Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? , 1997, The Journal of clinical investigation.

[30]  C. Stournaras,et al.  Endometrial corticotropin-releasing hormone. Its potential autocrine and paracrine actions. , 1997, Annals of the New York Academy of Sciences.

[31]  J. Gardosi,et al.  Reduction of False‐Positive Diagnosis of Fetal Growth Restriction by Application of Customized Fetal Growth Standards , 1996, Obstetrics and gynecology.

[32]  A. Sciscione,et al.  Adjustment of birth weight standards for maternal and infant characteristics improves the prediction of outcome in the small-for-gestational-age infant. , 1996, American journal of obstetrics and gynecology.

[33]  P. Björntorp.  Insulin resistance: the consequence of a neuroendocrine disturbance? , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[34]  B. Walker,et al.  11β-Hydroxysteroid Dehydrogenase and Its Inhibitors in Hypertensive Pregnancy , 1995 .

[35]  R. Goland,et al.  Corticotropin-releasing hormone and pituitary-adrenal hormones in pregnancies complicated by chronic hypertension. , 1995, American journal of obstetrics and gynecology.

[36]  B. Walker,et al.  11 beta-Hydroxysteroid dehydrogenase and its inhibitors in hypertensive pregnancy. , 1995, Hypertension.

[37]  R. Goland,et al.  Placental corticotropin-releasing hormone and the hypercortisolism of pregnancy. , 1994, American journal of obstetrics and gynecology.

[38]  V. Cameron,et al.  Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. , 1993, The Journal of clinical endocrinology and metabolism.

[39]  C. Chilvers,et al.  The individualised birthweight ratio: a more logical outcome measure of pregnancy than birthweight alone , 1993, British journal of obstetrics and gynaecology.

[40]  J. Gardosi,et al.  Customised antenatal growth charts , 1992, The Lancet.

[41]  G. Coukos,et al.  Involvement of Placental Neurohormones in Human Parturition a , 1991, Annals of the New York Academy of Sciences.

[42]  R. Kaaja,et al.  Corticotropin-releasing hormone in maternal and cord plasma in pre-eclampsia. , 1991, European journal of obstetrics, gynecology, and reproductive biology.

[43]  H. Mcgarrigle,et al.  The increase in plasma and saliva cortisol levels in pregnancy is not due to the increase in corticosteroid-binding globulin levels. , 1990, The Journal of clinical endocrinology and metabolism.

[44]  B. Allolio,et al.  DIURNAL SALIVARY CORTISOL PATTERNS DURING PREGNANCY AND AFTER DELIVERY: RELATIONSHIP TO PLASMA CORTICOTROPHIN‐RELEASING‐HORMONE , 1990, Clinical endocrinology.

[45]  G. Avvakumov,et al.  Specific steroid-binding glycoproteins of human blood plasma: novel data on their structure and function. , 1990, Journal of steroid biochemistry.

[46]  J. Challis,et al.  Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. , 1989, The Journal of clinical endocrinology and metabolism.

[47]  J. Potter,et al.  Corticosteroid binding globulin in normotensive and hypertensive human pregnancy. , 1987, Clinical science.

[48]  J L Coolens,et al.  Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. , 1987, Journal of steroid biochemistry.

[49]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[50]  G. Avvakumov,et al.  Pregnancy-associated molecular variants of human serum transcortin and thyroxine-binding globulin. , 1984, Carbohydrate research.

[51]  D. Krieger,et al.  Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy. , 1984, The Journal of clinical endocrinology and metabolism.

[52]  J. Foidart,et al.  Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy. , 1982, Journal of steroid biochemistry.

[53]  W. Nolten,et al.  Elevated free cortisol index in pregnancy: possible regulatory mechanisms. , 1981, American journal of obstetrics and gynecology.

[54]  B. Carr,et al.  Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy. , 1981, American journal of obstetrics and gynecology.

[55]  C. Migeon,et al.  The Metabolic Clearance Rate, Blood Production, Interconversion and Transplacental Passage of Cortisol and Cortisone in Pregnancy Near Term , 1973, Pediatric Research.

[56]  H. Rosenthal,et al.  Transcortin: a corticosteroid-binding protein of plasma. X. Cortisol and progesterone interplay and unbound levels of these steroids in pregnancy. , 1969, The Journal of clinical endocrinology and metabolism.

[57]  U. Seal,et al.  Corticosteroid-Binding Globulin: Biochemistry, Physiology, and Phylogeny* , 1966 .

[58]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.